“PASI Improvement in the First 12 weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE Guselkumab Clinical Trials”, J of Skin, vol. 7, no. 6, p. s237, Nov. 2023, doi: 10.25251/skin.7.supp.237.